Uric acid measurement (procedure)
|
phenotype |
|
Laboratory Procedure
|
264
|
1463
|
0.100 |
None |
1.000 |
2 |
5
|
2019 |
2019 |
Obesity, Visceral
|
phenotype |
Nutritional and Metabolic Diseases
|
Sign or Symptom
|
55
|
3
|
0.020 |
None |
0.500 |
2 |
1
|
2010 |
2019 |
Hematocrit procedure
|
phenotype |
|
Laboratory Procedure
|
138
|
216
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Hypertriglyceridemia
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
340
|
169
|
0.010 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
White Blood Cell Count procedure
|
phenotype |
|
Laboratory Procedure
|
681
|
1322
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Gestational Diabetes
|
phenotype |
Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
649
|
224
|
0.010 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Triglycerides measurement
|
phenotype |
|
Laboratory Procedure
|
563
|
1418
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
High density lipoprotein measurement
|
phenotype |
|
Laboratory Procedure
|
545
|
1440
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Measurement of liver enzyme
|
phenotype |
|
Laboratory Procedure
|
7
|
10
|
0.100 |
None |
1.000 |
1 |
1
|
2008 |
2008 |
Hemoglobin measurement
|
phenotype |
|
Laboratory Procedure
|
131
|
224
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Serum albumin measurement
|
phenotype |
|
Laboratory Procedure
|
433
|
3282
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Mean Corpuscular Volume (result)
|
phenotype |
|
Laboratory or Test Result
|
269
|
549
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Progressive Neoplastic Disease
|
phenotype |
|
Neoplastic Process
|
384
|
40
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Sarcopenia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
164
|
10
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Finding of liver enzyme levels
|
phenotype |
|
Laboratory or Test Result
|
7
|
10
|
0.100 |
None |
1.000 |
1 |
1
|
2008 |
2008 |
Cardiovascular morbidity
|
phenotype |
|
Disease or Syndrome
|
75
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cholestatic pruritus
|
phenotype |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Sign or Symptom
|
15
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Portal cirrhosis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
4
|
4
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Premature coronary artery atherosclerosis
|
phenotype |
Cardiovascular Diseases
|
Disease or Syndrome
|
87
|
43
|
0.010 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
|
phenotype |
|
Finding
|
63
|
|
0.200 |
None |
1.000 |
1 |
|
2015 |
2015 |
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2
|
phenotype |
|
Finding
|
63
|
|
0.200 |
None |
1.000 |
1 |
|
2015 |
2015 |
Portal fibrosis
|
phenotype |
Digestive System Diseases
|
Disease or Syndrome
|
15
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Adolescent Obesity
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
18
|
9
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Non-alcoholic Fatty Liver Disease
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1058
|
222
|
0.500 |
None |
0.977 |
220 |
15
|
2008 |
2020 |
Steatohepatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1143
|
75
|
0.500 |
None |
0.961 |
127 |
5
|
2009 |
2020 |